Abstract
In multiple sclerosis (MS), an inflammatory mechanism leads to demyelination and release of myelin proteins. The destroyed myelin is engulfed by macrophages as vesicular material. One of the most studied proteins is myelin basic protein (MBP), which constitutes about 30% of the protein component of central nervous system myelin: it is capable of inducing experimental allergic encephalomyelitis (EAE), an animal model close to MS pathology. MBP has been detected in the cerebrospinal fluid (CSF) of patients with MS during acute exacerbation up to two weeks after clinical onset, and is considered a reliable indicator of acute demyelination [1–3]. The MBP-like material detected in MS CSF has been extensively studied. By means of antisera recognizing different epitopes of the molecule, it was found that MBP circulating in CSF is a fragment containing an epitope corresponding to aminoacid residues 45–89 and that peptide 80–89 is the smallest sequence containing the dominant epitope [4]. The MBP epitope detected in CSF was found to be different from that in the urine of MS patients which corresponds to peptide 82–89 [5]. These findings suggest that MBP fragments released during myelin breakdown undergo enzymatic modification in the blood and additionally in the kidneys. They also contribute to understanding of the mechanism underlying MBP processing and how humoral and cellular immune responses directed against myelin proteins are elicited.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cohen SR, Herndon RM, McKhann GM (1976) Myelin basic protein in cerebrospinal fluid as an indicator of active demyelination. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. N Engl J Med 295:1454–1457
Whitaker JN (1977) Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology 27:911–920
Whitaker JN, Lisak RP, Bashir RM et al (1980) Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol 7:58–64
Whitaker JN, Gupta M, Smith OF (1986) Epitopes of immunoreactive myelin basic protein in human cerebrospinal fluid. Ann Neurol 20:329–336
Whitaker JN (1987) The presence of immunoreactive myelin basic protein peptide in urine of persons with multiple sclerosis. Ann Neurol 22:648–655
Prineas JW, Graham JS (1981) Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 10:149–158
Traugott U, Raine CS (1981) Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases. Neurology 31:695–700
Gorny MK, Wroblewska Z, Pleasure D, Miller SL, Wajgt A, Koprowski H (1983) CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases. Acta Neurol Scand 67:338–347
Steck A, Link H (1984) Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studies. Acta Neurol Scand 69:81–89
Lubetzki C, Lombrail P, Hauw JJ, Zalc B (1986) Multiple sclerosis: rat and human oligodendrocytes are not the target for CSF immunoglobulins. Neurology 36:524–528
Scolding NJ, Compston DA (1991) Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies. Immunology 72:127–132
Chou C-HJ, Tourtellotte W, Kibler RF (1983) Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS. Neurology 33:24–28
Garcia-Merino A, Persson MAA, Ernerudh J, Diaz-Gil JJ, Olsson T (1986) Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis. J Neurol Neurosurg Psychiatry 49:1066–1070
Cruz M, Olsson T, Ernerudh J, Hojeberg B, Link H (1987) Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis. Neurology 37:1515–1519
Warren K, Catz I (1987) A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients. Ann Neurol 21:183–189
Warren KG, Catz I (1988) Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission. J Neurol Sci 88:185–194
Olsson T, Henriksson A, Link H (1985) In vitro synthesis of immunoglobulins and autoantibodies by lymphocytes from various body compartments during chronic-relapsing experimental allergic encephalomyelitis. J Neuroimmunol 9:293–305
Gerritse K, Deen C, Fasbender M, Ravid R, Boersma W, Ciaassen E (1994) The involvement of specific anti-myelin basic protein antibody-forming cells in multiple sclerosis im-munopathology. J Neuroimmunol 49:153–159
Olsson T, Baig S, Hojeberg B, Link H (1990) Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann Neurol 27:132–136
Warren KG, Catz I (1993) Increased synthetic peptide specificity of tissue-CSF bound an-ti-MBP in multiple sclerosis. J Neuroimmunol 43:87–96
Annunziata P, Martino T, Maimone D, Guazzi GC (1994) Intrathecal IgM anti-MBP levels and prognosis in multiple sclerosis. J Neurol (Suppl 1) 241:S152
Warren KG, Catz I, Johnson E, Mielke B (1994) Anti-myelin basic protein and anti-pro-teolipid protein specific forms of multiple sclerosis. Ann Neurol 35:280–289
Sun J-B, Olsson T, Wang W-Z, Xiao B-G, Kostulas V, Fredrikson S, Ekre H-P, Link H (1991) Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 21:1461–1468
Sellebjerg FT, Fredriksen JL, Olsson T (1994) Anti-myelin basic protein and anti-prote-olipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis. Arch Neurol 51:1032–1036
Baig S, Olsson T, Yu-Ping J, Hojeberg B, Cruz M, Link H (1991) Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid. Scand J Immunol 33:73–79
Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of de-myelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin-oligodendrocyte glycoprotein. Am J Pathol 130:443–454
Sun J, Link H, Olsson T, Xiao BG, Andersson G, Ekre HP, Linington C, Diener P (1991) T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 146:1490–1495
Zanetta J-P, Tranchant C, Kuchler-Bopp S, Lehmann S, Warter JM (1994) Presence of anti-CSL antibodies in the cerebrospinal fluid of patients: a sensitive and specific test in the diagnosis of multiple sclerosis. J Neuroimmunol 52:175–182
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Italia, Milano
About this paper
Cite this paper
Annunziata, P. (1996). Cerebrospinal fluid markers of demyelination: MBP and anti-brain protein antibodies. In: Cerebrospinal Fluid Analysis in Multiple Sclerosis. Springer, Milano. https://doi.org/10.1007/978-88-470-2205-8_9
Download citation
DOI: https://doi.org/10.1007/978-88-470-2205-8_9
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2207-2
Online ISBN: 978-88-470-2205-8
eBook Packages: Springer Book Archive